1.4.1. Specific objective for biotechnology

Regulation (EU) No 1291/2013 of the European Parliament and of the Council of 11 December 2013 establishing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020) and repealing Decision No 1982/2006/EC Text with EEA relevance · European Union

The specific objective of biotechnology research and innovation is to develop competitive, sustainable, safe and innovative industrial products and processes and contribute as an innovation driver in a number of European sectors, like agriculture, forestry, food, energy, chemical and health as well as the knowledge-based bioeconomy. A strong scientific, technological and innovation base in biotechnology will support European industries securing leadership in this key enabling technology. This position will be further strengthened by integrating the health and safety assessment, the economic and environmental impact of use of the technology and the management aspects of the overall and specific risks in the deployment of biotechnology.

← 1.4. Biotechnology · All articles · anx_I__cpt_21__cpt_1__cpt_8__cpt_1__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-03 · Text as adopted (Official Journal); later amendments are not incorporated in this text.